Contact
Please use this form to send email to PR contact of this press release:
FDA approves Lucentis to treat diabetic retinopathy in patients with diabetic macular edema
TO:
Please use this form to send email to PR contact of this press release:
FDA approves Lucentis to treat diabetic retinopathy in patients with diabetic macular edema
TO: